COPD trials recruiting in Colorado

All COPD trials nationally

Cities in Colorado

Recruiting trials in Colorado

• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Colorado: Aurora, Denver, Englewood
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
  NCT07082738 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · Colorado: Lakewood
• An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
  NCT06035120 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · Colorado: Loveland
• Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
  NCT05937854 · Phase: Phase 2 · Ages: 35 Years to 89 Years · Sex: All (male and female) · Colorado: Aurora
• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
  NCT07059091 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · Colorado: Denver
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
  NCT06961214 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Colorado: Aurora
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
  NCT07190222 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Colorado: Boulder, Lakewood
• MoblO2 to Maintain Oxygenation
  NCT07704567 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 95 Years · Sex: All (male and female) · Colorado: Denver
• PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
  NCT05306743 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Denver
• Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease
  NCT05896579 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Colorado: Aurora
• PiMZ Longitudinal Cohort (PiMZ Logic)
  NCT06505603 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Denver
• Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
  NCT07576894 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Colorado: Aurora
• SPIROMICS Study of Early COPD Progression (SOURCE)
  NCT05033990 · Phase: Not specified · Ages: 30 Years to 55 Years · Sex: All (male and female) · Colorado: Denver
• To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
  NCT07684820 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Colorado: Aurora
• eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
  NCT07177339 · Phase: Phase 3 · Ages: 40 Years to 75 Years · Sex: All (male and female) · Colorado: Lakewood